Citation Impact
Citing Papers
Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib
2022
Telomere length in atherosclerosis and diabetes
2009
The current spectrum of infection in cancer patients with chemotherapy related neutropenia
2013
Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia
2013
National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: Scientific Opportunities in Extracorporeal Photopheresis
2014
Graft versus host disease: clinical evaluation, diagnosis and management
2013
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
The Clinical Utility of Biomarkers in the Management of Pancreatic Adenocarcinoma
2014
The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of Radiobiology
2013
TFOS DEWS II pathophysiology report
2017 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Targeted therapy for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: focus on brentuximab vedotin
2013
Telomere Shortening and Alzheimer’s Disease
2012
Extracorporeal photopheresis in acute and chronic graft-versus-host disease
2014
MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR–ABL protein
2014
Antimicrobial resistance: a global multifaceted phenomenon
2015 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Idarucizumab for Dabigatran Reversal
2015 Standout
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Chimeric antigen receptor T-cell therapies for lymphoma
2017
Peri/Epicellular Thiol Oxidoreductases as Mediators of Extracellular Redox Signaling
2020
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Focus on cannabinoids and synthetic cannabinoids
2016
G-CSF and GM-CSF in Neutropenia
2015
Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia
2018
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Chimeric Antigen Receptor Therapy
2018 Standout
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery
2019 Standout
Synthesis, anticancer activity and structure-activity relationship of some anticancer agents based on cyclopenta (b) thiophene scaffold.
2014
Telomere shortening leads to earlier age of onset in ALS mice
2016
Works of Ron Ram being referenced
Secondary malignancies following high dose therapy and autologous hematopoietic cell transplantation-systematic review and meta-analysis
2015
The role of protein disulfide isomerase in the post-ligation phase of β3 integrin-dependent cell adhesion
2015
Histology and Time to Progression Predict Survival for Lymphoma Recurring after Reduced-Intensity Conditioning and Allogeneic Hematopoietic Cell Transplantation
2011
Telomere dynamics in arteries and mononuclear cells of diabetic patients: Effect of diabetes and of glycemic control
2007
Renal failure associated with tyrosine kinase inhibitors—Case report and review of the literature
2009
Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study
2015
Rituximab‐associated acute thrombocytopenia: An under‐diagnosed phenomenon
2009
Oxidative stress causes telomere damage in Fanconi anaemia cells – a possible predisposition for malignant transformation
2008
Prophylaxis regimens for GVHD: systematic review and meta-analysis
2008
Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients
2012
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia
2011
High‐dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients—Systematic review and meta‐analysis
2011
Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato‐oncological patients: Randomized controlled trial
2013
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
2021
Risk factors and prognostic scale for cytomegalovirus (CMV ) infection in CMV ‐seropositive patients after allogeneic hematopoietic cell transplantation
2015
Ionizing Radiation Up-regulates Telomerase Activity in Cancer Cell Lines by Post-translational Mechanism via Ras/Phosphatidylinositol 3-Kinase/Akt Pathway
2009